PURPOSE OF REVIEW: This review focuses on recent literature on insulin resistance in youth with type 2 diabetes mellitus (T2DM). Insulin resistance is associated with a variety of cardiometabolic problems leading to increased morbidity and mortality across the lifespan. RECENT FINDINGS: Functional pancreatic β-cell changes play a role in the transition from obesity to impaired glucose tolerance (IGT). Insulin resistance drives islet cell upregulation, manifested by elevated glucagon and c-peptide levels, early in the transition to IGT. Surrogate measurements of insulin resistance and insulin secretion exist but their accuracy compared to clamp data is imperfect. Recent large longitudinal studies provide detailed information on the progression from normoglycemia to T2DM and on the phenotype of T2DM youth. Defining prediabetes and T2DM remains a challenge in youth. Lifestyle interventions do not appear as effective in children as in adults. Metformin remains the only oral hypoglycemic agent approved for T2DM in youth. SUMMARY: New insights exist regarding the conversion from insulin resistance to T2DM, measurement of insulin resistance and phenotypes of insulin resistance youth, but more information is needed. Surrogate measurements of insulin resistance, additional treatment options for insulin resistance and individualization of treatment options for T2DM adolescents in particular require further investigation.
PURPOSE OF REVIEW: This review focuses on recent literature on insulin resistance in youth with type 2 diabetes mellitus (T2DM). Insulin resistance is associated with a variety of cardiometabolic problems leading to increased morbidity and mortality across the lifespan. RECENT FINDINGS:Functional pancreatic β-cell changes play a role in the transition from obesity to impaired glucose tolerance (IGT). Insulin resistance drives islet cell upregulation, manifested by elevated glucagon and c-peptide levels, early in the transition to IGT. Surrogate measurements of insulin resistance and insulin secretion exist but their accuracy compared to clamp data is imperfect. Recent large longitudinal studies provide detailed information on the progression from normoglycemia to T2DM and on the phenotype of T2DM youth. Defining prediabetes and T2DM remains a challenge in youth. Lifestyle interventions do not appear as effective in children as in adults. Metformin remains the only oral hypoglycemic agent approved for T2DM in youth. SUMMARY: New insights exist regarding the conversion from insulin resistance to T2DM, measurement of insulin resistance and phenotypes of insulin resistance youth, but more information is needed. Surrogate measurements of insulin resistance, additional treatment options for insulin resistance and individualization of treatment options for T2DM adolescents in particular require further investigation.
Authors: Valeriya Lyssenko; Peter Almgren; Dragi Anevski; Roland Perfekt; Kaj Lahti; Michael Nissén; Bo Isomaa; Björn Forsen; Nils Homström; Carola Saloranta; Marja-Riitta Taskinen; Leif Groop; Tiinamaija Tuomi Journal: Diabetes Date: 2005-01 Impact factor: 9.461
Authors: Aaron L Carrel; R Randall Clark; Susan E Peterson; Blaise A Nemeth; Jude Sullivan; David B Allen Journal: Arch Pediatr Adolesc Med Date: 2005-10
Authors: D Dabelea; R B D'Agostino; C C Mason; N West; R F Hamman; E J Mayer-Davis; D Maahs; G Klingensmith; W C Knowler; K Nadeau Journal: Diabetologia Date: 2010-10-01 Impact factor: 10.122
Authors: Mary Savoye; Paulina Nowicka; Melissa Shaw; Sunkyung Yu; James Dziura; Georgia Chavent; Grace O'Malley; John B Serrecchia; William V Tamborlane; Sonia Caprio Journal: Pediatrics Date: 2011-02-07 Impact factor: 7.124
Authors: Stacey L Simon; Cecilia Diniz Behn; Melanie Cree-Green; Jill L Kaar; Laura Pyle; Stephen M M Hawkins; Haseeb Rahat; Yesenia Garcia-Reyes; Kenneth P Wright; Kristen J Nadeau Journal: J Pediatr Date: 2018-11-26 Impact factor: 4.406
Authors: Banshi Saboo; Sanjay Agarwal; Sunil Gupta; Brij Makkar; A Panneerselvam; Abhay Kumar Sahoo; G D Ramchandani; Sambit Das; Suhas Erande; Yogesh Kadam; Mahesh V Abhyankar; Santosh Revankar Journal: J Family Med Prim Care Date: 2021-09-30